Fujifilm to Seek Approval for Covid Drug After Trial Results

Bookmark
(Bloomberg) -- Fujifilm Holdings Corp. said it would seek regulatory approval in Japan to market an antiviral drug as a treatment for Covid-19, after a trial showed that it helped patients with mil...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.